[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "(484) 875-3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 681200, "exercisedValue": 0, "unexercisedValue": 5637696}, {"maxAge": 1, "name": "Mr. Henry  Hagopian III, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 375000, "exercisedValue": 0, "unexercisedValue": 373438}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.72, "open": 8.72, "dayLow": 8.03, "dayHigh": 9.08, "regularMarketPreviousClose": 8.72, "regularMarketOpen": 8.72, "regularMarketDayLow": 8.03, "regularMarketDayHigh": 9.08, "beta": 1.761, "forwardPE": -3.8980582, "volume": 451681, "regularMarketVolume": 451681, "averageVolume": 533169, "averageVolume10days": 727030, "averageDailyVolume10Day": 727030, "bidSize": 1000, "askSize": 1000, "marketCap": 89707144, "fiftyTwoWeekLow": 4.79, "fiftyTwoWeekHigh": 22.49, "fiftyDayAverage": 9.7068, "twoHundredDayAverage": 10.2046, "currency": "USD", "enterpriseValue": 59542284, "floatShares": 8142966, "sharesOutstanding": 11171500, "sharesShort": 1607610, "sharesShortPriorMonth": 1504524, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.1459, "heldPercentInsiders": 0.25564, "heldPercentInstitutions": 0.12019, "shortRatio": 2.1, "shortPercentOfFloat": 0.19590001, "impliedSharesOutstanding": 11171500, "bookValue": -0.737, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -56204312, "trailingEps": -6.23, "forwardEps": -2.06, "52WeekChange": -0.40430266, "SandP52WeekChange": 0.26362717, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "messageBoardId": "finmb_622711087", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.03, "targetHighPrice": 72.0, "targetLowPrice": 13.0, "targetMeanPrice": 33.5, "targetMedianPrice": 24.5, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 5754720, "totalCashPerShare": 0.523, "quickRatio": 1.345, "currentRatio": 2.386, "returnOnAssets": -1.21768, "returnOnEquity": -5.4639697, "freeCashflow": -23747072, "operatingCashflow": -39967304, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-17"}]